Waksal, Julian A.
Mascarenhas, John
Article History
Accepted: 22 July 2022
First Online: 19 August 2022
Declarations
:
: JW reports no conflicts of interest. JM receives clinical research funding paid to the institution from Incyte, Novartis, Roche, Merck, Kartos, CTI Bio, PharmaEssentia, Geron, Promedior, Forbius, and Celgene/BMS, and consulting fees from Incyte, Celgene/BMS, Roche, Novartis, Sierra Oncology, CTI Bio, PharmaEssentia, Constellation, Kartos, and Karyopharm.
: This article does not contain any studies with human or animal subjects performed by any of the authors.